Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Daily News

Post-TAVI Neurologic Problems an Ongoing Issue

Todd Neale

August 16, 2024

News Daily News

Women and Minorities Underrepresented in Heart Valve Trials

L.A. McKeown

July 27, 2023

News Daily News

Radiation Exposure Highest for Interventional Imagers at Right Waist and Below

Yael L. Maxwell

March 29, 2023

Registry Results See Less PVL, Pacemakers With Acurate neo2

Shelley Wood

November 29, 2022

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

News Daily News

‘Considerable’ Aortic Stenosis Burden in UK Begs Money and a Plan

Michael O'Riordan

January 28, 2022

News Daily News

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

Michael O'Riordan

November 18, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2020

Shelley Wood

October 30, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

Presentation TCT 2020

SCOPE I: One-year outcomes of a randomized trial comparing a self-expanding to a balloon-expandable transcatheter aortic valve

Presenter: Thomas Walther

October 17, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

Presentation TCT 2020

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Presenter: Corrado Tamburino

October 15, 2020

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News ESC 2019

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

L.A. McKeown

September 05, 2019

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

Advertisement

Post-TAVI Neurologic Problems an Ongoing Issue

Women and Minorities Underrepresented in Heart Valve Trials

Radiation Exposure Highest for Interventional Imagers at Right Waist and Below

Registry Results See Less PVL, Pacemakers With Acurate neo2

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

‘Considerable’ Aortic Stenosis Burden in UK Begs Money and a Plan

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

TCTMD’s Top 10 Most Popular Stories for October 2020

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

SCOPE I: One-year outcomes of a randomized trial comparing a self-expanding to a balloon-expandable transcatheter aortic valve

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Portico Noninferior to Commercial TAVR Valves in IDE Study

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

TCT 2019 Day Two: Transcatheter Valves, New and Old

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content